Investing in, developing and Commercializing Transformational solutions for patients that combine:

Drug Device Cell therapy Diagnostics Informatics

We invest in, develop and commercialize BioConvergent solutions that provide enhanced outcomes for patients
BioConvergent Solutions involve the combination of drug, device, cell, diagnostic and informatics products and services

We have a world-class, international, cross-disciplinary team that has unique combinations of expertise in R&D (pharmaceutical, medical device, cell therapy, diagnostic, informatics, data science), investing, business development, legal and finance

We are a uniquely structured company with R&D and commercial BioConvergent capabilities
We integrate mature and emerging differentiated assets, capabilities and intellectual property
Our portfolio consists of commercial products and services and high growth and R&D stage products